Four years after the US FDA issued a warning that blood pressure drugs containing olmesartan can cause a severe gastrointestinal disorder, Public Citizen is calling on the agency to remove them from the market.
In a Nov. 15 citizen petition, the group includes a compilation of studies on the incidence of sprue-like enteropathy,...




